Home LiteratureArticle Details
PMID: 7543878 Published · ppublish English Journal Article Review

Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Infection and immunity ·Vol. 63 ·No. 9 ·1995-09-00 ·Pages 3241-4

Taylor CE

Abstract

The use of cytokines in the administration of vaccines has a unique value in obtaining the appropriate immune response and in ensuring a protective outcome. Earlier studies indicating that cytokines can influence the generation of a particular antibody isotype may represent an oversimplification of a more complex problem. Several studies discussed in this review show that the effect of a given cytokine on the immune response depends on whether one examines the antigen-specific response or the polyclonal response (i.e., total serum immunoglobulins). Further, a balanced regulation of immune responsiveness is important in maintaining homeostasis of the immune system. Consequently, for any vaccine that uses cytokines to boost the response, due consideration must be given to these important variables.

MeSH Terms
Adjuvants, Immunologic/pharmacology Animals Antibody Formation/drug effects B-Lymphocytes/immunology Cytokines/pharmacology Epitopes Humans Vaccines/immunology
Chemicals
Adjuvants, Immunologic Cytokines Epitopes Vaccines
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Taylor C E
Division of Microbiology & Infectious Diseases, National Institute of Allergy and Infectious Diseases, Rockville, Maryland 20892-7630, USA.
References (48)
48 references, click to expand
  1. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.
    N Engl J Med. 1983 Aug 25;309(8):453-8 PMID: 6224088
  2. Effects of interferon gamma on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice.
    Immunobiology. 1994 Dec;192(1-2):106-20 PMID: 7750985
  3. IgG2a restriction of murine antibodies elicited by viral infections.
    J Exp Med. 1987 Jan 1;165(1):64-9 PMID: 3794607
  4. Inhibition of T cell-dependent antibody production by D-penicillamine. Different requirements for Cu2+ in suppression of polyclonal and antigen-specific B cell responses.
    Allergy. 1987 Jan;42(1):37-45 PMID: 3551672
  5. Increased activation of antigen-primed or memory B cells by bacterial lipopolysaccharide.
    Cell Immunol. 1987 Jul;107(2):263-72 PMID: 3496160
  6. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
    J Immunol. 1988 Feb 15;140(4):1022-7 PMID: 3125247
  7. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant.
    Cell Immunol. 1989 Oct 1;123(1):1-8 PMID: 2776217
  8. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
    Scand J Immunol. 1990 Jan;31(1):25-31 PMID: 1689073
  9. Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens.
    FASEB J. 1990 May;4(8):2518-27 PMID: 2110538
  10. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching.
    Proc Natl Acad Sci U S A. 1990 May;87(10):3962-6 PMID: 2339132
  11. Lymphokine control of in vivo immunoglobulin isotype selection.
    Annu Rev Immunol. 1990;8:303-33 PMID: 1693082
  12. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.
    Infect Immun. 1990 Nov;58(11):3465-8 PMID: 2228218
  13. Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.
    Infect Immun. 1991 Feb;59(2):575-9 PMID: 1824762
  14. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones.
    J Exp Med. 1991 Mar 1;173(3):747-50 PMID: 1997653
  15. IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching.
    Cell Immunol. 1991 Jun;135(1):95-104 PMID: 1902147
  16. Generation and analysis of interleukin-4 deficient mice.
    Science. 1991 Nov 1;254(5032):707-10 PMID: 1948049
  17. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection.
    Infect Immun. 1992 Feb;60(2):450-4 PMID: 1730475
  18. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli.
    Cell Immunol. 1992 Feb;139(2):426-37 PMID: 1370764
  19. Antigen-specific and polyclonal CD4+ lamina propria T-cell lines: phenotypic and functional characterization.
    Immunology. 1992 Jan;75(1):66-73 PMID: 1371494
  20. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.
    Eur J Immunol. 1992 Mar;22(3):711-7 PMID: 1547817
  21. Role of IL-6 in human antigen-specific and polyclonal IgA responses.
    Adv Exp Med Biol. 1991;310:113-21 PMID: 1808988
  22. Cytokines. Poking holes in the network.
    Nature. 1992 May 7;357(6373):16-7 PMID: 1349426
  23. Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage.
    Cell Immunol. 1992 Aug;143(1):66-79 PMID: 1377990
  24. Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.
    Res Immunol. 1992 Jun;143(5):483-8; discussion 573-4 PMID: 1439127
  25. In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection.
    Immunobiology. 1992 Sep;185(5):475-82 PMID: 1360445
  26. Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma.
    Parasitol Res. 1992;78(8):629-34 PMID: 1480597
  27. In vitro antigen-specific IgE response is refractory to suppression by interferon-gamma.
    Immunol Lett. 1992 Oct-Nov;34(2):99-104 PMID: 1487304
  28. Interferon-gamma and resistance to bacterial infections.
    APMIS. 1993 Jan;101(1):1-17 PMID: 8457320
  29. Interleukin 6 is not required for antigen-specific antibody responses by human B cells.
    Eur J Immunol. 1993 Apr;23(4):984-7 PMID: 8458386
  30. Autoimmunity, polyclonal B-cell activation and infection.
    Lupus. 1992 Feb;1(2):63-74 PMID: 1301966
  31. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease.
    Am J Pathol. 1993 Jul;143(1):3-9 PMID: 8317552
  32. Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation.
    Nutr Cancer. 1993;19(3):269-80 PMID: 8346076
  33. Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal Plasmodium yoelii malaria.
    Mem Inst Oswaldo Cruz. 1992 Apr-Jun;87(2):197-204 PMID: 1284989
  34. Antigen-specific but not polyclonal IgE response in murine B cells cocultured with Th2 clone is refractory to suppression by IL4-depletion.
    Int Arch Allergy Immunol. 1993;102(2):152-9 PMID: 7691299
  35. Cytokine regulation of T-cell function: potential for therapeutic intervention.
    Trends Pharmacol Sci. 1993 May;14(5):164-8 PMID: 8105593
  36. Effects of IL-4 depletion on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice.
    Immunobiology. 1993 Aug;188(4-5):379-91 PMID: 8244445
  37. Recombinant cytokines as immunological adjuvants.
    Immunol Cell Biol. 1993 Oct;71 ( Pt 5):367-79 PMID: 8270266
  38. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.
    Science. 1994 Jan 14;263(5144):235-7 PMID: 7904381
  39. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
    J Clin Immunol. 1993 Nov;13(6):381-8 PMID: 7507125
  40. Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein.
    J Infect Dis. 1994 Apr;169(4):787-91 PMID: 8133093
  41. The B cell-specific transcription factor BSAP regulates B cell proliferation.
    J Exp Med. 1994 Apr 1;179(4):1099-108 PMID: 7511679
  42. Activation of nuclear factor kappa B in human neuroblastoma cell lines.
    J Neurochem. 1994 May;62(5):1716-26 PMID: 8158122
  43. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.
    J Exp Med. 1994 May 1;179(5):1725-9 PMID: 7513017
  44. Cytokines and tuberculosis.
    J Leukoc Biol. 1994 May;55(5):676-81 PMID: 8182346
  45. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.
    Infect Immun. 1994 Jun;62(6):2257-69 PMID: 8188347
  46. Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo.
    Eur J Immunol. 1994 Jun;24(6):1396-403 PMID: 8206100
  47. Prolonged in vivo IL-4 treatment inhibits antigen-specific IgG1 and IgE formation.
    Scand J Immunol. 1994 Jul;40(1):1-9 PMID: 8029636
  48. Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome.
    Clin Immunol Immunopathol. 1986 Jun;39(3):359-67 PMID: 2938858
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1995-09-00
Pages
3241-4
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC173446
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]